Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.67 |
| ▸ | NPC1 | O15118 | 6/20 | 0.65 |
| ▸ | RAB9A | P51151 | 6/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.61 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.61 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.59 |
| ▸ | PGR | P06401 | 1/20 | 0.59 |
| ▸ | JAK2 | O60674 | 1/20 | 0.58 |
| ▸ | TYK2 | P29597 | 1/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | PLG | P00747 | 1/20 | 0.56 |
| ▸ | PLAU | P00749 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL363881 | 0.93 | PTPN1 (0.67) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL126415 | 0.86 | PTPN1 (0.87) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL18103163 | 0.84 | NPC1 (0.88) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL14715824 | 0.84 | NPC1 (0.88) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL11596555 | 0.84 | KCNK3 (0.59) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL14072817 | 0.84 | PTPN1 (0.65) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL1344198 | 0.84 | F2 (0.72) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL27289941 | 0.82 | NPC1 (0.61) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL1535148 | 0.82 | NPC1 (0.50) | PTPN1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL26953087 | 0.82 | PTPN1 (0.88) | PTPN1NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2417144-B1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | GLYCOM AS (DK) | 2017-08-23 | — | — | EP | disclosed |
| EP-2417143-B1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | GLYCOM AS (DK) | 2016-12-21 | — | — | EP | disclosed |
| US-20160024129-A1 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES | GLYCOM A/S (DK) | 2016-01-28 | — | — | US | disclosed |
| US-9187513-B2 | N-substituted mannosamine derivatives, process for their preparation and their use | GLYCOM A/S (DK) | 2015-11-17 | — | — | US | disclosed |
| US-9102966-B2 | Synthesis of sialooligosaccharide derivatives | GLYCOM A/S (DK) | 2015-08-11 | — | — | US | disclosed |
| US-9012625-B2 | Method for the synthesis of a trisaccharide | GLYCOM A/S (DK) | 2015-04-21 | — | — | US | disclosed |
| US-8927698-B2 | Method for the synthesis of a trisaccharide | GLYCOM A/S (DK) | 2015-01-06 | — | — | US | disclosed |
| US-20140349347-A1 | SYNTHESIS OF N-ACETYL-D-NEURAMINIC ACID | GLYCOM A/S (DK) | 2014-11-27 | — | — | US | disclosed |
| EP-2791349-A1 | SYNTHESIS OF N-ACETYL-D-NEURAMINIC ACID | Glycom A/S (DK) | 2014-10-22 | — | — | EP | disclosed |
| WO-2014135167-A1 | PURIFICATION OF OLIGOSACCAHARIDES BY REVERSIBLE DERIVATIZATION | GLYCOM A/S (DK) | 2014-09-12 | — | — | WO | disclosed |
| EP-2417144-A1 | SYNTHESIS OF 2 ' -O-FUCOSYLLACTOSE | Glycom A/S (DK) | 2012-02-15 | — | — | EP | disclosed |
| EP-2417143-A1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | Glycom A/S (DK) | 2012-02-15 | — | — | EP | disclosed |
| WO-2012007588-A1 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES | GLYCOM A/S (DK) | 2012-01-19 | — | — | WO | disclosed |
| WO-2012007585-A1 | DERIVATIZATION OF OLIGOSACCHARIDES | GLYCOM A/S (DK) | 2012-01-19 | — | — | WO | disclosed |
| WO-2010115935-A1 | SYNTHESIS OF 2 ' -O-FUCOSYLLACTOSE | GLYCOM A/S (DK) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010115934-A1 | SYNTHESIS OF 2'-O-FUCOSYLLACTOSE | GLYCOM A/S (DK) | 2010-10-14 | — | — | WO | disclosed |
| WO-2003028762-A1 | NOVEL ANTIMICROBIAL RESISTANCE BLOCKING COMPOSITIONS | ETHICON, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
| US-4933355-A | ALDOSE REDUCTASE INHIBITORS | SANKYO COMPANY LIMITED (JP) | 1990-06-12 | — | — | US | disclosed |
| EP-0337819-A1 | Thiazole derivatives, their preparation and their use in the treatment of diabetes complications | Sankyo Company Limited (JP) | 1989-10-18 | — | — | EP | disclosed |
| US-3931142-A | Heterocyclic containing disazo compounds | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024129-A1 | SYNTHESIS OF NEW SIALOOLIGOSACCHARIDE DERIVATIVES | FUCA1, FUT5, FUCA2 | PTPN1 3558/4885NPC1 2003/4885RAB9A 823/4885 |
| US-20140349347-A1 | SYNTHESIS OF N-ACETYL-D-NEURAMINIC ACID | NAPRT, NAMPT, NANS | PTPN1 4106/4885NPC1 742/4885RAB9A 4147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.